Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 6905-6913
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6905
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6905
Table 3 Treatment of gastric cancer n (%)
| Variable | Age ≤45 yr(n = 202) | Age > 45 yr (n = 1456) | P value |
| Endoscopic resection | 9 (4.5) | 192 (13.2) | 0.516 |
| EMR | 6 (3.0) | 104 (7.1) | |
| ESD | 3 (1.5) | 88 (6.0) | |
| Operation | 172 (85.1) | 1160 (79.7) | 0.018 |
| Curative resection | 157 (77.7) | 1108 (76.1) | |
| Palliative resection | 15 (7.4) | 52 (3.6) | |
| LN dissection | 0.017 | ||
| Not performed | 9 (4.5) | 24 (1.6) | |
| N1 | 62 (30.7) | 404 (27.7) | |
| N2 | 95 (47.0) | 714 (49.0) | |
| N3 | 6 (3.0) | 18 (1.2) | |
| Radiation | 0.101 | ||
| No | 197 (97.5) | 1440 (98.9) | |
| Yes | 5 (2.5) | 16 (1.1) | |
| Chemotherapy | < 0.001 | ||
| No | 132 (65.3) | 1194 (82.1) | |
| Yes | 70 (34.7) | 261 (17.9) |
- Citation: Seo JY, Jin EH, Jo HJ, Yoon H, Shin CM, Park YS, Kim N, Jung HC, Lee DH. Clinicopathologic and molecular features associated with patient age in gastric cancer. World J Gastroenterol 2015; 21(22): 6905-6913
- URL: https://www.wjgnet.com/1007-9327/full/v21/i22/6905.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i22.6905